Navigating Economic Resilience Through Life Sci...

By João L. Carapinha

January 20, 2026

Navigating a Leaderless Global Economy Through Life Sciences Investment In an era of deepening geopolitical fragmentation, often termed the G-Zero world, global...
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
INFARMED Leadership Appointments: A New Era in Health Regulation and Expertise
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft ...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Emblaveo MDR Infections: Evaluating a New Solution for Multidrug-Resistant Gr...
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
FDA Cancer Trial Guidelines: Prioritizing Overall Survival for Patient-Center...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...
UK Pharmaceutical Pricing Analysis: Impasse in VPAG Review Undermines Patient...
Achieving International Drug Price Parity: Trump’s Mandate